Modernas stock price (MRNA) edged up in the intraday levels, amid the dominance of the upward correctional trend in the short term, with positive pressure from the 50-day SMA, countered with negative signals from the RSI.
Therefore we expect more gains for the stock, targeting the pivotal resistance of 115.00, provided the support of 99.27 holds on.
Trend forecast: Bullish